Tens-of-millions of women every year test positive for human papillomavirus (HPV) at
routine cervical screening. We performed a mixed-methods systematic review using a …

Self‐collection of samples for human papillomavirus (HPV) testing has the potential to
increase the uptake of cervical screening among underscreened women and will likely form …

In human papillomavirus (HPV) cervical cancer screening, cytology is used as triage to
counter the low specificity of HPV testing. VALID‐SCREEN is a EU‐multicenter …

Background High-risk human papillomavirus (hrHPV) testing on self-collected samples has
potential as a primary screening tool in cervical screening, but real-world evidence on its …

Background Many breast, cervical, and colorectal cancer screening programmes were
disrupted due to the COVID-19 pandemic. This study aimed to estimate the effects of five …

PURPOSE Cervical screening can prevent cancer by detection and treatment of cervical
intraepithelial neoplasia grade 2 or 3 (CIN2/3). Screening also results in considerable …

Background Randomized controlled trials have shown a higher sensitivity and longer
negative predictive value of high-risk human papillomavirus (HPV) testing than cytology for …

Objective To compare the costs and effects of three sampling strategies for human
papillomavirus (HPV) primary screening. Design Cost-consequence analysis from a health …

Background Excisional procedures of cervical intraepithelial neoplasia (CIN) may increase
the risk of preterm birth. It is unknown whether this increased risk is due to the excision …

Background Indigenous women in the high‐income countries of Canada, Australia, New
Zealand and USA, have a higher incidence and mortality from cervical cancer than non …